Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-9

Belantamab mafodotin for relapsed or refractory multiple myeloma

Manuel David Gil-Sierra, Maria del Pilar Briceño-Casado

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2020

The role of belantamab mafodotin for patients with relapsed and/or refractory multiple myeloma

Melody R. Becnel, Hans C. Lee

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2024-09

Corneal Toxicity in Patients Treated by BELANTAMAB MAFODOTIN: How to Improve and Facilitate Patients Follow-Up Using Refractive Shift?

Jason Chauvier, Marie-Caroline Trone, Philippe Gain [...]

Journal of Ocular Pharmacology and Therapeutics

Retricted access

Review article

First published 2021-8

Updates in the management of relapsed/refractory multiple myeloma

Kirollos S Hanna, Samantha Larson, Jenny Nguyen [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2022-6

The emergence of b-cell maturation antigen (BCMA) targeting immunotherapy in multiple myeloma

James A. Davis, Abigail Shockley, Hamza Hashmi

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2021

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies

Larysa Sanchez, Alexandra Dardac, Deepu Madduri [...]

Therapeutic Advances in Hematology

Open access

Review article

First published 2022

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma

Mary Steinbach, Kelley Julian, Brian McClune [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2023-01

Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma

Kandice A. Kapinos, Ellen Hu, Jigar Trivedi [...]

Cancer Control

Search results